This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Astellas Pharma Gmbh, Tokyo Medical and Dental University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Satoru Egawa: Innovator in Hemostatic Technology
Introduction
Satoru Egawa is a notable inventor based in Bunkyo, Japan. He has made significant contributions to the field of medical technology, particularly in the area of hemostatic solutions for surgical procedures. His innovative approach has led to the development of a unique product that enhances surgical outcomes.
Latest Patents
Satoru Egawa holds a patent for a thrombin-carrying hemostatic sheet. This invention is designed to facilitate hemostasis during surgeries, especially spine surgeries. The hemostatic sheet is characterized by its convenience, as it requires no preparation before use. It is also bioabsorbable, allowing it to be embedded in the body safely. The composition of the sheet includes a gelatin sponge that carries an effective amount of thrombin, with specific parameters: a density of 30 to 55 mg/cm and a shape maintaining angle in wet conditions of 55 to 120°.
Career Highlights
Throughout his career, Satoru Egawa has worked with prestigious organizations, including Tokyo Medical and Dental University and Astellas Pharma GmbH. His experience in these institutions has contributed to his expertise in medical innovations and product development.
Collaborations
Satoru has collaborated with notable colleagues such as Yasuharu Kimura and Keiichi Yoshihara. These partnerships have played a crucial role in advancing his research and development efforts.
Conclusion
Satoru Egawa's contributions to the field of hemostatic technology exemplify the impact of innovative thinking in medicine. His patent for the thrombin-carrying hemostatic sheet represents a significant advancement in surgical practices, enhancing patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile